A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
A post gaining significant traction on Reddit r/artificial this weekend makes an argument that cuts against the dominant narrative in AI coverage: the biggest productivity gains don't come from using the newest model. They come from building disciplined, stable workflows around whatever model is already good enough — and stopping there. Every time a new benchmark drops and teams scramble to swap their stack, they're paying a real switching cost that rarely shows up in the productivity math.
The argument resonates because it matches the experience of the practitioners who've actually shipped AI-powered products. The integrations, the prompt engineering, the error handling, the edge cases — that work doesn't transfer when you change the underlying model. For businesses, integration discipline consistently beats benchmark-chasing as a productivity strategy.
The deeper implication is worth sitting with. If the model is increasingly commoditized — if GPT-5, Claude, and Gemini are all good enough for most tasks — then the competitive advantage shifts to who builds better workflows on top of them. That's a software engineering and product design problem, not an AI research problem. The model wars may determine who wins in the lab. The plumbing wars will determine who wins in the market.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division